SLS-005 clinical trials

A DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TRIAL TO ASSESS SAFETY AND EFFICACY OF SLS-005 (TREHALOSE INJECTION, 90.5 MG/ML FOR INTRAVENOUS INFUSION) FOR THE TREATMENT OF ADULTS WITH SPINOCEREBELLAR ATAXIA

This study is testing a new medicine, SLS-005, for adults with a condition called Spinocerebellar Ataxia type-3 (SCA3). Researchers want to see if it improves movement and daily activities, and if it's safe to use.